About Akero Therapeutics, Inc.

Akero Therapeutics, Inc. operates as a biotechnology company. The firm specializes in transformational treatments for non-alcoholic steatohepatitis (NASH) and other serious metabolic diseases. The company was founded by Jonathan Young and Timothy Rolph on January 24, 2017 and is headquartered in South San Francisco, CA.

At the moment the company doesn't generate any revenue.

On its last earning announcement, the company reported a loss of -0.95$ per share.

The book value per share is 5.01$

Akero Therapeutics, Inc. website


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
- - -32M - -90M -0.95 - - 29M 5.01 -26M -5M -26M